HORIZON (OP-106): Melflufen Plus Dexamethasone (dex) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM) Exposed to Prior Alkylator Therapy-Subgroup Analysis

This article has no abstract
Epistemonikos ID: 8cb9b83a793594fe5aa662fc41c06232cd61032b
First added on: Feb 12, 2025